May 30 (Reuters) - Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the company of scheming to delay a generic version of its ...

AstraZeneca signs AI research deal with China's CSPC for chronic diseases AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...

The deal would be among the largest in a wave of opioid settlements. It calls for members of the Sackler family who own the ...

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma ...

The multi-billion-dollar payment is meant to resolve claims that the drugmaker's pain medication, OxyContin, caused an opioid ...

WASHINGTON (7News) — Maryland, Virginia, and D.C. attorneys general have joined a coalition of 55 attorneys general that have ...

A federal judge is urging NASCAR and two of its teams to settle their increasingly acrimonious legal fight that spilled over ...

More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler ...

Johnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege the company’s Baby Powder talc products caused cancer, according to Bloomberg. Citing people ...

The multi-billion dollar settlement will create revenue sharing and NIL enforcement, but it won’t stop legal challenges to ...